Immunophenotypic Findings
| Patients . | Case No. . | |||
|---|---|---|---|---|
| . | 1 . | 2 . | 3 . | 4 . |
| Surface antigen (%) | ||||
| CD2 | 42.4 | 32.4 | 29.3 | 12.3 |
| CD5 | 38.7 | 29.2 | 28.6 | 9.0 |
| CD11c | 57.5 | 77.2 | 49.5 | 83.4 |
| CD19 | NT | 68.3 | 78.0 | 94.0 |
| CD22 | 54.9 | 63.7 | 49.5 | 83.4 |
| CD24 | 6.6 | NT | 9.1 | 12.0 |
| CD25 | 1.8 | <1.0 | <1.0 | 4.6 |
| SIg (%) | ||||
| IgG | 33.7 | 37.2 | 47.5 | 59.9 |
| IgM | 2 | 4.8 | 3.8 | 3.8 |
| Igκ | 19.4 | 28.6 | 36.4 | 24.2 |
| Igλ | 18.7 | 16.9 | 20.3 | 22.9 |
| Patients . | Case No. . | |||
|---|---|---|---|---|
| . | 1 . | 2 . | 3 . | 4 . |
| Surface antigen (%) | ||||
| CD2 | 42.4 | 32.4 | 29.3 | 12.3 |
| CD5 | 38.7 | 29.2 | 28.6 | 9.0 |
| CD11c | 57.5 | 77.2 | 49.5 | 83.4 |
| CD19 | NT | 68.3 | 78.0 | 94.0 |
| CD22 | 54.9 | 63.7 | 49.5 | 83.4 |
| CD24 | 6.6 | NT | 9.1 | 12.0 |
| CD25 | 1.8 | <1.0 | <1.0 | 4.6 |
| SIg (%) | ||||
| IgG | 33.7 | 37.2 | 47.5 | 59.9 |
| IgM | 2 | 4.8 | 3.8 | 3.8 |
| Igκ | 19.4 | 28.6 | 36.4 | 24.2 |
| Igλ | 18.7 | 16.9 | 20.3 | 22.9 |
Abbreviation: NT, not tested.